Niki BioSolutions (NIKI) stock
NIKI · Niki BioSolutions Inc. · NASDAQ
- Market cap
- $4.9M
- EPS (FY)
- -$0.19
- Shares out
- 2.9M
What is the latest news on NIKI stock?
SECago
SEC Form NT 10-Q filed by Niki BioSolutions Inc.
NT 10-Q - Niki BioSolutions, Inc. (0001734005) (Filer)
All NIKI newsFinancial highlights
Full financials- Net income, FY2025
- -$1.36M
- Cash
- $3.45M
For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.
Latest news
4 items- SECSEC Form NT 10-Q filed by Niki BioSolutions Inc.NT 10-Q - Niki BioSolutions, Inc. (0001734005) (Filer)
- INSIDERPresident & COO Alidad Mireskandari converted options into 20,000 shares (SEC Form 4)4 - Niki BioSolutions, Inc. (0001734005) (Issuer)
- INSIDERSEC Form 3 filed by new insider Freeburg Thomas John3 - Niki BioSolutions, Inc. (0001734005) (Issuer)
- PRNiki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2026 ConferencePresentation highlights APOE genotype testing via a quick fingertip prick validated in Niki BioSolutions’ CLIA-certified laboratory and recently approved by the New York State Department of Health NEW HAVEN, CT, and PRINCETON, NJ, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ:NIKI) ("Niki BioSolutions" or the "Company"), a clinical-stage life sciences company focused on developing advanced genomic and biomarker testing solutions, today announced that its wholly owned subsidiary, DiamiR Biosciences Corp. ("DiamiR"), will be presenting a poster at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) conference on Wednesday, November 19th, in Boston, MA. Poster Presen
News · 26 weeks4+100%
2026-05-242026-11-15
Mix490d
- Other2(50%)
- Insider2(50%)
Activity · 52 weeks43 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Niki BioSolutions Inc. (NIKI) is an Industrial Machinery/Components company listed on NASDAQ. In the last 30 days Quantisnow tracked 4 wire items for NIKI, including 2 press releases and news items and 2 insider trades. The most recent was published Nov 17, 2026.
NIKI FAQ
8 questionsWhat does Niki BioSolutions Inc. do?
Niki BioSolutions is a clinical-stage life sciences company focused on addressing unmet medical needs by developing high-quality genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Through its CLIA-certified, CAP-accredited laboratory, the Company combines proprietary technologies with scientific rigor to support precision medicine across a range of therapeutic areas. Niki BioSolutions collaborates with leading academic centers, disease foundations, and biopharmaceutical companies.Is NIKI profitable?
No. Niki BioSolutions Inc. reported a net loss of $1.36M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does NIKI have?
Niki BioSolutions Inc. reported $3.45M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does NIKI stock trade?
Niki BioSolutions Inc. (NIKI) is listed on NASDAQ.What sector and industry is NIKI in?
Niki BioSolutions Inc. operates in the Industrials sector, Industrial Machinery/Components industry.When did Niki BioSolutions Inc. go public?
Niki BioSolutions Inc. (NIKI) completed its IPO in 2018.What companies are similar to NIKI?
Notable peers in the same industry include ETN (Eaton Corporation PLC), JCI (Johnson Controls International plc), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ASML (ASML Holding N.V. New York Registry Shares). Compare NIKI side-by-side with any of them on Quantisnow.How can I track NIKI on Quantisnow?
Quantisnow aggregates Niki BioSolutions Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NIKI to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change